GenSight Biologics S.A.

SIGHT.PA · PAR
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents€2,464€2,134€10,610€44,288
Short-Term Investments€0€0€0€0
Receivables€1€1€3,490€754
Inventory€0-€1€8,482€4,368
Other Curr. Assets€2,035€2,444-€8,117-€415
Total Curr. Assets€5,343€6,529€22,947€53,363
Property Plant & Equip (Net)€933€2,025€2,268€2,549
Goodwill€0€0€0€0
Intangibles€57€75€93€112
Long-Term Investments€4,423€503€633€0
Tax Assets€0€0-€633€0
Other NC Assets€0€0€633€624
Total NC Assets€5,413€2,603€2,994€3,285
Other Assets€0€0€0€0
Total Assets€10,756€9,132€25,941€56,648
Liabilities
Payables€6,357€5,634€7,813€11,561
Short-Term Debt€13,314€16,605€1,535€4,675
Tax Payable€171€25€25€24
Deferred Revenue€0€0€0€37
Other Curr. Liab.€2,362€488€789€2,782
Total Curr. Liab.€22,618€25,290€14,642€22,242
LT Debt€4,700€5,107€9,246€5,644
Deferred Rev, NC€0€0€193€420
Deferred Tax Liab, NC€0€0€0€41
Other NC Liab.€9,844€8,389€11,146€6,322
Total NC Liab.€15,058€14,544€26,578€18,416
Other Liabilities€0€0€0€0
Cap. Leases€1,099€1,823€1,866€2,247
Total Liabilities€37,676€39,834€41,220€40,658
Equity
Pref Stock€0€197,052€0€137,727
Common Stock€3,119€1,633€1,158€1,158
Retained Earnings-€14,001-€26,220-€27,625-€28,617
AOCI-€222,644-€197,052-€170,023-€137,727
Other Equity€0-€197,052-€170,097-€137,726
Total Equity-€26,920-€30,668-€15,279€15,990
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€10,756€9,132€25,941€56,648
Net Debt€15,550€19,578€171-€33,969